泰格医药：2023数字化和去中心化临床试验行业发展现状调研分析报告（43页）.pdf

1、1Customer-centric and globally adaptive DCT solutions Release date:2024.1.32023?/?2?.3?.4?.5?.11?.25?.34?.39?.41?.42?/?3?务?尽?确?/?务?务?/?务?务?务?/?务?889889?/?497?,?392?,?/?务?尽?尽?尽?副?尽?务?尽?/?4?研?2023?务?889?5?DCT?DCT?/?5?01?/?619192.1%40040045.0%36536541.1%999911.1%6 60.7%?25-44?25-34?35-44?39.5%?39.1%?/?

2、务?45%?41.1%?/?务?研?11.1%?23232.6%34734739.5%34434439.1%12912914.7%36364.1%?25?25-34?35-44?45-54?65?/?务?务?/?务?务?/?7?55.9%?/?务?务?CRO?/?18.9%?16.6%?SMO?DCT?尽?尽?43.1%?36.7%?尽?18.9%?/?务?尽?尽?500?尽?36.5%?10,000?副?尽?19.1%?/?务?尽?务?尽?14814816.6%49749755.9%16816818.9%39394.4%30303.4%7 70.8%?/?/?CROSMODCT?其他?143

3、14336.5%434311.0%656516.6%666616.8%757519.1%?尽?尽?500?5001,000?1,0005,000?5,00010,000?10,000?14414436.7%747418.9%1 10.3%4 41.0%16916943.1%?尽?尽?/?8?59.9%?IT?研?/?务?务?尽?务?32.4%?22.4%?CRC?副?6.6%?/?务?务?DCT?23523559.9%545413.8%28287.1%26266.6%14143.6%13133.3%13133.3%4 1.0%2 0.5%2 20.5%1 10.3%?尽?尽?IT?数据管理统计

4、临床药理药物警戒采购财务868621.9%26266.6%17174.3%9 92.3%888822.4%12712732.4%13133.3%26266.6%?尽?尽?CRACRC?经理软件工程师高层管理人员(副总裁及以上)?/?9?/?研?94.8%?3.6%?0.8%?0.2%?0.4%?研?研?/?务?务?务?/?9.3%?7.8%?副?/?务?务?47247295.0%18183.6%1 10.2%4 40.8%2 20.4%?/?/?10?46.1%?42.4%?9.9%?1.6%?/?务?副?DCT?DCT?22922946.1%49499.9%21121142.5%8 81.6

5、%?/?11?02?/?12?DCT?/?(?2013?-?)?DCT?,?,?/?务?岁?DCT?28.8%?DCT?导?2013?映?/?务?务?CRO?52.4%?25625628.8%63363371.2%?岁?岁?DCTDCT?969619.3%40140180.7%?岁333322.3%11511577.7%?808047.6%888852.4%CROCRO?/?13?DCTDCT?DCT?/?DCT?,?(eCOA)?研?(eConsent)?务?16.7%?14.4%?12.1%?11.2%?9.8%?去?务?DCT?研?(eCOA)?(eConsent)?/?14?DCT 务

6、?(eCOA)?19.5%?13.6%?DTP?11.9%?(eConsent)?10.2%?研?10.2%)?6.8%?1.7%?CROs?DCT?务?eCOA?(eConsent)?DCT?/?/?15?研?/?务?娴?52.3%?模?务?务?映?/?务?副?47.6%?模?务?19.9%?32.4%?:?100%?19.919.919.9%32.432.432.4%47.647.647.6%模?/?16?3?DCT?(2024-2026)?DCT?务?务?DCT?确?研?CRO?DCT?/?务?DCT?务?59.6%?35.2%?DCT?务?5.2%?岁?DCT?确?务?24.9%?DC